文献速递心脑血管急症创伤与烧伤重症综合管理与镇静镇痛

钝性脑血管损伤的抗血栓选择:三级创伤中心经验、系统评价与Meta分析

Antithrombotic choice in blunt cerebrovascular injuries: Experience at a tertiary trauma center, systematic review, and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论Meta分析显示抗血小板与抗凝预防钝性脑血管损伤缺血性卒中的效果似乎相似,但抗血小板出血更少,作者认为可能优选抗血小板,尚需前瞻性随机试验。

本研究为回顾性综述、系统评价与Meta分析,比较抗血小板(AP)与抗凝(AC)治疗钝性脑血管损伤(BCVI)患者的缺血性卒中率和出血并发症。共纳入22项研究及本机构2010至2015年数据,合计2044例BCVI患者。两组卒中率无显著差异(OR 1.27,95%CI 0.40-3.99),AP组出血率较AC组降低(OR 0.38,95%CI 0.15-1.00)。作者认为两者预防卒中似乎同样有效,但AP在创伤人群中耐受性更好,可能优选AP,需前瞻性随机试验进一步评估。

要点

  • 共2044例BCVI患者(22项研究加本机构数据),AP与AC组卒中率无显著差异(OR 1.27,95%CI 0.40-3.99)。
  • AP组出血率较AC组降低(OR 0.38,95%CI 0.15-1.00),提示AP在创伤人群中耐受性更好。
  • 作者认为AP可能优选用于BCVI抗血栓治疗,但需前瞻性随机试验进一步评估。
  • 本机构为2010至2015年三级创伤中心BCVI患者的回顾性综述,与系统评价和Meta分析合并报告。
  • 证据等级为综述文章II级。

适用人群与场景

  • 钝性脑血管损伤(BCVI)患者,年龄18岁及以上,来自本三级创伤中心2010至2015年回顾性数据及系统检索的文献。
  • 纳入标准:报告BCVI患者接受AP或AC治疗后按治疗分层的临床结局的研究。
  • 排除标准:病例报告、n<5的病例系列、综述文章、会议摘要、动物研究、非同行评议出版物。

研究设计与关键结果

  • 研究类型:本机构回顾性综述加系统评价与Meta分析;共纳入22项研究及本机构数据,合计2044例BCVI患者。
  • 主要结局:AP组与AC组卒中率无显著差异(OR 1.27,95%CI 0.40-3.99)。
  • 次要结局:AP组出血率较AC组降低(OR 0.38,95%CI 0.15-1.00)。
  • 合并估计采用随机效应模型,以Mantel-Hanzel权重法合并OR。
  • 检索数据库:OVID Medline、Embase、Web of Science、Cochrane Library,检索至2019年9月16日;手工检索纳入文献的参考文献;检索限人类、18岁及以上、英文。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析(含本机构回顾性综述)。
  • 证据等级:综述文章,II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为AP与AC预防BCVI缺血性卒中似乎同样有效,但AP在创伤人群中耐受性更好,提示AP治疗可能优选。
  • 作者建议该结果应通过前瞻性随机试验进一步评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Blunt cerebrovascular injuries (BCVIs) may occur following trauma and lead to ischemic stroke if untreated. Antithrombotic therapy decreases this risk; however, the optimal agent has yet to be determined in this population. The aim of this study was to compare the risk-benefit profile of antiplatelet (AP) versus anticoagulant (AC) therapy in rates of ischemic stroke and hemorrhagic complications in BCVI patients.

METHODS: We performed a retrospective review of BCVI patients at our tertiary care Trauma hospital from 2010 to 2015, and a systematic review and meta-analysis of the literature. The OVID Medline, Embase, Web of Science, and Cochrane Library databases were searched from inception to September 16, 2019. References of included publications were searched manually for other relevant articles. The search was limited to articles in humans, in patients 18 years or older, and in English. Studies that reported treatment-stratified clinical outcomes following AP or AC treatment in BCVI patients were included. Exclusion criteria included case reports, case series with n < 5, review articles, conference abstracts, animal studies, and non-peer-reviewed publications. Data were extracted from each study independently by two reviewers, including study design, country of origin, sex and age of patients, Injury Severity Score, Biffl grade, type of treatment, ischemic stroke rate, and hemorrhage rate. Pooled estimates using odds ratio (OR) were combined using a random-effects model using a Mantel-Hanzel weighting. The main outcome of interest was rate of ischemic stroke due to BCVI, and the secondary outcome was hemorrhage rate based on AC or AP treatment.

RESULTS: In total, there were 2044 BCVI patients, as reported in the 22 studies in combination with our institutional data. The stroke rate was not significantly different between the two treatment groups (OR, 1.27; 95% confidence interval, 0.40-3.99); however, the hemorrhage rate was decreased in AP versus AC treated groups (OR, 0.38; 95% confidence interval, 0.15-1.00).

CONCLUSION: Based on this meta-analysis, both AC and AP seem similarly effective in preventing ischemic stroke, but AP is better tolerated in the trauma population. This suggests that AP therapy may be preferred, but this should be further assessed with prospective randomized trials.

LEVEL OF EVIDENCE: Review article, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Ku JC, Priola SM, Mathieu F, et al. Antithrombotic choice in blunt cerebrovascular injuries: Experience at a tertiary trauma center, systematic review, and meta-analysis. J Trauma Acute Care Surg. 2021. PMID: 34144568. doi:10.1097/TA.0000000000003194

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。